Belite Bio, Inc (BLTE)
NASDAQ: BLTE · Real-Time Price · USD
146.57
-3.71 (-2.47%)
Oct 23, 2026, 2:18 PM EDT - Market open
Belite Bio Market Cap
Belite Bio has a market cap or net worth of $5.9 billion as of October 23, 2026. It is the 3,098th most valuable company in the world and the 1,013th biggest in the United States. Its market cap has increased by 89.31% in one year.
Market Cap
5.90B
Enterprise Value
5.41B
1-Year Change
89.31%
Global Rank
Country Rank
#1,013 United States
Category
ChartMarket Cap Chart
Since the IPO on April 29, 2022, Belite Bio's market cap has increased from $144.57M to $5.90B, an increase of 3,982.73%. That is a compound annual growth rate of 128.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 5.90B | -1.64% |
| Dec 31, 2025 | 6.00B | 207.97% |
| Dec 31, 2024 | 1.95B | 54.32% |
| Dec 29, 2023 | 1.26B | 68.44% |
| Dec 30, 2022 | 749.63M | 418.52% |
| Apr 29, 2022 | 144.57M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Praxis Precision Medicines | 7.38B |
| Iovance Biotherapeutics | 6.73B |
| Rhythm Pharmaceuticals | 6.21B |
| Ligand Pharmaceuticals | 6.11B |
| Immunovant | 5.91B |
| Kodiak Sciences | 5.83B |
| Mirum Pharmaceuticals | 5.52B |
| CG Oncology | 5.49B |